Recombinant interferon-alpha, but not interferon-gamma is effective therapie for essential thrombocythemia
Author:
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine,Hematology
Link
http://link.springer.com/content/pdf/10.1007/BF01720201.pdf
Reference23 articles.
1. Bellucci S, Harousseau JL, Brice P, Tobelem G (1988) Treatment of essential thrombocythaemia by alpha 2a interferon. Lancet II: 960–961
2. Case DC Jr (1984) Therapy of essential thrombocythemia with thiotepa and chlorambucil. Blood 63: 51–54
3. Giles FJ, Gray AG, Brozovic M, Grant IR, Machin SJ, Richards JDM, Venutas S, Singer CRJ, Young KL, Davies SC, Hoffbrand AV, Mehta AB, Thomas MJG, Goldstone AH (1988) Alpha-interferon therapy for essential thrombocythaemia. Lancet II: 70–72
4. Gisslinger H, Linkesch W, Fritz E, Ludwig H, Chott A, Radaszkiewicz Th (1989) Long-term interferon therapy for thrombocytosis in myeloproliferative diseases. Lancet I: 634–637
5. Gugliotta L, Bagnara GP, Catani L, Gaggioli L, Guarini A, Zauli G, Belmonte MM, Lauria F, Macchi S, Tura S (1989) In vivo and in vitro inhibitory effect of α-interferon on megakaryocyte colony growth in essential thrombocythaemia. Br J Haematol 71: 177–181
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interferon alpha therapy in essential thrombocythemia and polycythemia vera—a systematic review and meta-analysis;Leukemia;2020-09-01
2. Drug-Related Cutaneous Adverse Events in Philadelphia Chromosome-Negative Myeloproliferative Neoplasms: A Literature Review;International Journal of Molecular Sciences;2020-05-30
3. Developmental differences in IFN signaling affect GATA1s-induced megakaryocyte hyperproliferation;Journal of Clinical Investigation;2013-07-01
4. The in vitro effects of interferon-gamma, interferon-alpha, and tumour-necrosis factor-alpha on erythroid burst-forming unit growth in patients with non-leukaemic myeloproliferative disorders;European Journal of Haematology;2009-04-24
5. Remission may continue after termination of rIFNα -2b treatment for essential thrombocythemia;European Journal of Haematology;2009-04-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3